|
TIPIN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.158200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.942300E-02 |
| Normal-vs-Stage2 |
7.725700E-02 |
| Normal-vs-Stage3 |
3.081800E-02 |
| Normal-vs-Stage4 |
1.094490E-02 |
| Stage1-vs-Stage2 |
7.752800E-01 |
| Stage1-vs-Stage3 |
5.768800E-01 |
| Stage1-vs-Stage4 |
3.407400E-01 |
| Stage2-vs-Stage3 |
9.057400E-01 |
| Stage2-vs-Stage4 |
5.926200E-01 |
| Stage3-vs-Stage4 |
6.356200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.739900E-02 |
| Normal-vs-AfricanAmerican |
4.158400E-01 |
| Normal-vs-Asian |
3.573000E-04 |
| Caucasian-vs-AfricanAmerican |
8.276600E-01 |
| Caucasian-vs-Asian |
9.977200E-03 |
| AfricanAmerican-vs-Asian |
1.758780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.243100E-03 |
| Normal-vs-Female |
3.341600E-02 |
| Male-vs-Female |
2.259000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.701800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.398200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.166450E-01 |
| Normal-vs-Age(81-100Yrs) |
1.571160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.120100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.485000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.542600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.212000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.924400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.369800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.033700E-04 |
| Classical-VS-Follicular |
9.850200E-01 |
| Classical-VS-Other |
6.720800E-01 |
| Classical-VS-Normal |
1.012220E-01 |
| Tall-VS-Follicular |
2.604000E-03 |
| Tall-VS-Other |
6.788800E-01 |
| Tall-VS-Normal |
8.19890000000045E-05 |
| Follicular-VS-Other |
6.727400E-01 |
| Follicular-VS-Normal |
1.332050E-01 |
| Other-VS-Normal |
4.107800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.200500E-02 |
| Normal-vs-N1 |
8.509800E-02 |
| N0-vs-N1 |
6.711200E-01 |
|
|
